AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2026)

AdaptHealth's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$204.5 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 113.9% year-over-year to -$204.5 million; the TTM figure through Mar 2026 stood at -$412.1 million (down 29.59% YoY), while the FY2025 annual figure was -$303.2 million, up 2.28% from the prior year.
• Cash from Investing Activities was -$204.5 million for Q1 2026 at AdaptHealth, down from -$124.5 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $9.6 million in Q2 2025 to a low of -$204.5 million in Q1 2026.
• Historically, Cash from Investing Activities has averaged -$93.3 million across 5 years, with a median of -$89.9 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities soared 111.82% in 2025, then tumbled 113.9% in 2026.
• A 5-year view of Cash from Investing Activities shows it stood at -$145.8 million in 2022, then soared by 37.98% to -$90.4 million in 2023, then increased by 3.92% to -$86.9 million in 2024, then tumbled by 43.28% to -$124.5 million in 2025, then sank by 64.26% to -$204.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$204.5 million (Q1 2026), -$124.5 million (Q4 2025), and -$92.7 million (Q3 2025), per Business Quant data.